COVID-19疫苗接种后FDG PET/MRI心肌炎症与临床结局
症状性心肌炎组中2/17有局灶性FDG摄取,3/17有MRI T2高信号;其余两组无局灶FDG摄取、心肌水肿或心室功能受损。结论:仅少数早期诊断为急性心肌炎的接种者随访时显示心肌炎症证据。
要点
- 接种后2个月,症状性心肌炎组仅2/17出现局灶FDG摄取,3/17 T2高信号。
- 症状性无心肌炎及无症状组均无局灶FDG摄取、心肌水肿或心室功能受损。
- 无心肌炎以外的不良心脏事件,症状性心肌炎组生活质量低于无症状组。
关键影像表现/征象
- 症状性心肌炎组中2例有局灶性FDG摄取,3例MRI T2高信号。
- 症状性无心肌炎组及无症状组均无局灶FDG摄取、心肌水肿或心室功能受损。
诊断标准与关键数值
- 症状性心肌炎定义为接种后14天内出现新发心脏症状且符合急性心肌炎诊断标准。
- 症状性无心肌炎定义为有新发心脏症状但不符合心肌炎诊断标准。
临床应用与阅片要点
- 对接种后早期诊断心肌炎者,2个月随访PET/MRI可能仍显示局灶FDG摄取或T2高信号。
- 无心肌炎的接种后症状者及无症状者,PET/MRI未见心肌炎症或功能受损征象。
局限性
- 仅随访至接种后约2个月,无更长期影像随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate potential cardiac sequelae of COVID-19 vaccination at 2-month follow-up and relate cardiac symptoms to myocardial tissue changes on fluorodeoxyglucose (FDG) PET/MRI, blood biomarkers, health-related quality of life, and adverse outcomes.
MATERIALS AND METHODS: In this prospective study (ClinicalTrials.gov: NCT04967807), a convenience sample of individuals aged ≥17 years were enrolled after COVID-19 vaccination and were categorized as symptomatic myocarditis (new cardiac symptoms within 14 days of vaccination and met diagnostic criteria for acute myocarditis), symptomatic no myocarditis (new cardiac symptoms but did not meet criteria for myocarditis), and asymptomatic (no new cardiac symptoms). Standardized evaluation was performed 2 months after vaccination, including cardiac fluorine 18 FDG PET/MRI, blood biomarkers, and health-related quality of life. Statistical analysis included Kruskal-Wallis and Fisher exact tests.
RESULTS: Fifty-four participants were evaluated a median of 72 days (IQR: 42, 91) after COVID-19 vaccination, 17 symptomatic with myocarditis (36±[SD]15 years, 13 males), 17 symptomatic without myocarditis (42±12 years, 7 males), and 20 asymptomatic (45±14 years, 9 males). No participants in the symptomatic without myocarditis or asymptomatic groups had focal FDG-uptake, myocardial edema or impaired ventricular function. Two participants with symptomatic myocarditis had focal FDG-uptake, and three had high T2 on MRI. Health-related quality of life was lower in the symptomatic myocarditis group than the asymptomatic group. There were no adverse cardiac events beyond myocarditis in any participant.
CONCLUSIONS: At two-month follow-up, FDG PET/MRI showed evidence of myocardial inflammation in 2/17 participants diagnosed with acute myocarditis early after COVID-19 vaccination, but not in symptomatic and asymptomatic participants without acute myocarditis.Keywords: Myocarditis, Vaccination, COVID-19, PET/MRI, Cardiac MRI, FDG-PET.
引用
- Marschner, Thavendiranathan, Gustafson, et al. Myocardial Inflammation on FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination. Radiol Cardiothorac Imaging. 2023. PMID: 36987440. doi:10.1148/ryct.220247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。